US stocks closed | After the interest rate cut, US stocks rose and then fell back, with the three major indices closing slightly lower. Apple bucked the trend and rose nearly 2%.
After the Federal Reserve cut interest rates, US stock index hit a new daily high. However, it turned downwards after Powell's press conference. The S&P 500 ended its seven-day winning streak, while the Dow Jones Industrial Average fell for the second consecutive day. Nvidia failed to rebound and closed down nearly 2%, while Apple rose against the trend, gaining nearly 2%.
Novo Nordisk Inks $600M Genetic Medicines Pact With Canadian Firm To Target Cardiometabolic Indications
ResMed Slips as Wolfe Downgrades on GLP-1 Threat From Lilly
10 Health Care Stocks With Whale Alerts In Today's Session
Sen. Sanders Says Generic Drugmakers Willing to Sell Ozempic for Less Than $100
Over a hundred former Republican officials have written an open letter supporting Harris: Trump is not suitable to regain the White House.
① These Republican officials have served in institutions such as the White House, Department of Defense, Department of the Treasury, Department of State, Department of Justice, Department of Homeland Security, and Congress; ② These officials expressed that although there may be policy differences with Harris, compared to the "chaos and unethical behavior" displayed by Trump, these concerns are insignificant.
NanoVation Therapeutics Announces Multi-Year Partnership With Novo Nordisk To Develop Genetic Medicines Targeting Cardiometabolic And Rare Diseases, With Potential Payments Up To $600M And Tiered Royalties
Jim Cramer Labels Moderna A 'Big Disappointment,' But Suggests Doubling Down On Another Pharma Powerhouse
The yen's slight rebound led to a slight buying back movement.
The Nikkei Average rebounded and closed at 36,380.17 yen, up 176.95 yen (+1.5 billion 30 million shares of volume traded). With the yen's strength easing during the U.S. market hours the previous day, the Tokyo market opened with buying focused on automobile and technology stocks leading to a rebound in the Nikkei Average. However, shortly after the start of trading, it rose to 36,675.07 yen, but then the subsequent results of the Federal Open Market Committee (FOMC) and the press conference by Federal Reserve Board (FRB) Chairman Powell were analyzed.
Active and newly listed stocks during the morning session.
*Trancom <9058> 8830 down - announcement of MBO implementation prompts TOB price adjustment. *Mitsui Ocean Development <6269> 3050 +314 UBS Securities raises target stock price. *Tsuburaya Fi HD <2767> 2475 +225 expects positive material with the announcement of Fields' new pachislot machine. *SHIFT <3697> 13630 +1160 breaks above the cloud upper limit of Ichimoku chart. *TOKYO BASE <3415> 247 +19 substantial increase in profit in the second quarter as well.
Looking Into Eli Lilly's Recent Short Interest
Benzinga Market Summary: Bitcoin Rises, Oil Gains On Supply Impacts, Novo Nordisk Falls Amid Pricing Comments From Exec And Criticism From Sen. Sanders
What the Options Market Tells Us About Viking Therapeutics
Rhythm Pharma Draws Bullish View at JMP on Opportunity in Rare Genetic Obesities
Unpacking the Latest Options Trading Trends in Eli Lilly
Pfizer Unusual Options Activity
Major breakthrough in cancer treatment? Pharmaceutical companies invest billions of dollars, competing to bet on targeted radiation therapy.
Radioactive drugs have the potential to become a significant breakthrough in cancer treatment. In the past year, global pharmaceutical giants such as bristol-myers squibb, astrazeneca, and eli lilly and co have invested approximately 10 billion US dollars to actively enter the field of radioactive drugs through acquisitions and collaborations, aiming to replicate the success of Novartis in the drugs Lutathera and Pluvicto. Currently, these radioactive drugs are mainly used to treat certain types of neuroendocrine tumors and prostate cancer, with the potential to expand to the treatment of more types of cancer in the future.
With FOMC looming, there was volatile movement throughout, but it managed to hold at 36,000 yen by the close.
The Nikkei average posted a significant decline. It ended the trading at 36,203.22 yen, down 378.54 yen (trading volume approximately 1.870 million shares). Although the Nikkei average started with a rebound in the morning due to the new record high of the NY Dow in the U.S. market on the 16th, it softened after reaching the high of 36,663.18 yen. Against the background of the anticipation of a substantial interest rate cut in the U.S., the yen exchange rate temporarily reached the 139 yen level against the dollar during the three-day weekend, the highest level in about a year and two months. As a result, concerns about the performance of export companies gradually heightened, leading to the Nikkei average.
Beyond The Numbers: 13 Analysts Discuss Pfizer Stock
Cantor Fitzgerald Reiterates Overweight on Pfizer, Maintains $45 Price Target